• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Research and Markets: Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

    Research and Markets: Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

  2. Oncolytics Biotech® Inc. Presents at the 2015 Immune Checkpoint Inhibitors Meeting

    Oncolytics Biotech® Inc. Presents at the 2015 Immune Checkpoint Inhibitors Meeting

  3. GenVec and TheraBiologics form Collaboration to Develop Neural Stem Cell Mediated Cancer Therapies

    GenVec and TheraBiologics form Collaboration to Develop Neural Stem Cell Mediated Cancer Therapies

  4. Oncolytics Biotech® Inc. Announces 2014 Year End Results

    Oncolytics Biotech® Inc. Announces 2014 Year End Results

  5. Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Primary Peritoneal Cancer

    Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Primary Peritoneal Cancer

  6. Oncolytics Biotech® Inc. Collaborators Present Preclinical Data on the Combination of REOLYSIN® and Radiotherapy in Melanoma at the Irish Association for Cancer Research Conference

    Oncolytics Biotech® Inc. Collaborators Present Preclinical Data on the Combination of REOLYSIN® and Radiotherapy in Melanoma at the Irish Association for Cancer Research Conference

  7. Aptose Biosciences to Present at the 27th Annual ROTH Conference

    Aptose Biosciences to Present at the 27th Annual ROTH Conference

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.